Cargando…
Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
Bruton Tyrosine Kinase (BTK) has a key role in multiple pathways involved in inflammation and autoimmunity. Therefore, BTK has become a new therapeutic target for a group of hematologic and autoimmune disorders. The pharmaceutical industry has invested in the clinical development of BTK inhibitors d...
Autores principales: | Patsatsi, Aikaterini, Murrell, Dedee F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382970/ https://www.ncbi.nlm.nih.gov/pubmed/34447768 http://dx.doi.org/10.3389/fmed.2021.708071 |
Ejemplares similares
-
Translational autoimmunity in pemphigus and the role of novel Bruton tyrosine kinase inhibitors
por: Naik, Piyu Parth
Publicado: (2022) -
Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study
por: Murrell, D.F., et al.
Publicado: (2021) -
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond
por: Mahmoudi, Hamidreza, et al.
Publicado: (2022) -
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II
por: Patsatsi, Aikaterini, et al.
Publicado: (2023) -
Inhibition of Bruton's Tyrosine Kinase Protects Against Burn Sepsis-Induced Intestinal Injury
por: Wan, Jia, et al.
Publicado: (2022)